Related Experiment Video
Updated: Jan 7, 2026

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome
Published on: April 25, 2025
Tympanostomy tubes and developmental outcomes at 9 to 11 years of age
Jack L Paradise1, Heidi M Feldman, Thomas F Campbell
1University of Pittsburgh, Pittsburgh, USA. jpar@pitt.edu
Insights
Prompt tympanostomy tube insertion for persistent middle-ear effusion in young children does not improve long-term developmental outcomes. This study found no significant differences in literacy, attention, or academic achievement up to 11 years of age.
Area of Science:
- Pediatric Otolaryngology
- Child Development
- Evidence-Based Medicine
Background:
- Persistent middle-ear effusion in early childhood is linked to developmental impairments.
- Previous research showed no cognitive or language benefits from early tympanostomy tube insertion up to age 6.
- Longer-term developmental outcomes required further investigation.
Purpose of the Study:
- To evaluate the long-term effects of prompt versus delayed tympanostomy tube insertion on child development.
- To assess outcomes in literacy, attention, social skills, and academic achievement.
Main Methods:
- 6350 infants were monitored for middle-ear effusion.
- 429 children with persistent effusion were randomized to prompt or delayed tympanostomy tube insertion (up to 9 months later).
- Literacy, attention, and academic achievement were assessed at 9-11 years in 391 children.
Main Results:
- No significant differences were observed in 48 developmental measures between early and delayed tympanostomy tube groups.
- Specific measures included reading comprehension, spelling, writing, calculation, and inattention ratings.
- Scores on standardized tests like Woodcock Reading Mastery Tests and Woodcock-Johnson III were comparable.
Conclusions:
- Prompt tympanostomy tube insertion does not enhance developmental outcomes in otherwise healthy children with persistent middle-ear effusion up to 9-11 years of age.
- The findings support a watchful waiting approach for non-urgent cases.
- This study provides long-term data on the efficacy of early surgical intervention for middle-ear effusion.
Background:
Developmental impairments in children have been attributed to persistent middle-ear effusion in their early years of life. Previously, we reported that among children younger than 3 years of age with persistent middle-ear effusion, prompt as compared with delayed insertion of tympanostomy tubes did not result in improved cognitive, language, speech, or psychosocial development at 3, 4, or 6 years of age. However, other important components of development could not be assessed until the children were older.
Methods:
We enrolled 6350 infants soon after birth and evaluated them regularly for middle-ear effusion. Before 3 years of age, 429 children with persistent effusion were randomly assigned to undergo the insertion of tympanostomy tubes either promptly or up to 9 months later if effusion persisted. We assessed literacy, attention, social skills, and academic achievement in 391 of these children at 9 to 11 years of age.
Results:
Mean (+/-SD) scores on 48 developmental measures in the group of children who were assigned to undergo early insertion of tympanostomy tubes did not differ significantly from the scores in the group that was assigned to undergo delayed insertion. These measures included the Passage Comprehension subtest of the Woodcock Reading Mastery Tests (mean score, 98+/-12 in the early-treatment group and 99+/-12 in the delayed-treatment group); the Spelling, Writing Samples, and Calculation subtests of the Woodcock-Johnson III Tests of Achievement (96+/-13 and 97+/-16; 104+/-14 and 105+/-15; and 99+/-13 and 99+/-13, respectively); and inattention ratings on visual and auditory continuous performance tests.
Conclusions:
In otherwise healthy young children who have persistent middle-ear effusion, as defined in our study, prompt insertion of tympanostomy tubes does not improve developmental outcomes up to 9 to 11 years of age. (ClinicalTrials.gov number, NCT00365092 [ClinicalTrials.gov].).
Related Concept Videos
05:12Murine Nasal Lavage Fluid Collection without Blood Contamination
03:40Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome
04:35Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment
08:47Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
06:49Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
07:15Intranasal Administration of CNS Therapeutics to Awake Mice

